Keyphrases
Acute Stroke
8%
Asian Patients
5%
Atrial Fibrillation
16%
CHAMP
8%
Chronic Progressive
11%
Clinical Correlation
8%
Clinical Outcomes Research
8%
Corticosteroid Therapy
8%
Corticosteroids
8%
Current Therapies
8%
Environmental Exposure
8%
First Clinical Demyelinating Event
8%
Fracture Type
8%
Guillain-Barré Syndrome
16%
Healthy Controls
13%
High Risk
8%
Immune Activation
8%
Immune Defense
8%
India
16%
Inducer
8%
Low-dose Steroids
8%
Lymphocyte Subsets
8%
Magnetic Resonance Imaging
16%
Measles Vaccination
8%
Measles Virus
6%
Movement Disorders
8%
MS Patients
12%
Multiple Pregnancy
8%
Multiple Sclerosis
100%
Multiple Sclerosis Treatment
21%
Neopterin
8%
Neurological Diseases
16%
New Therapies
8%
On-state Current
16%
Patient Management
8%
Pharmacological Treatment
8%
Progressive MS
14%
Progressive multiple Sclerosis
29%
Quality of Care
8%
Recurrent Stroke
8%
Sex Hormones
8%
Sham
6%
Soluble interleukin-2 Receptor (sIL-2R)
9%
Stroke Patients
8%
Stroke Prevention
8%
T Cell Activation
6%
T Cells
16%
Telemedicine
8%
United States
12%
Neuroscience
Atrial Fibrillation
8%
Brainstem
9%
CD4
5%
Cell Activation
6%
Cerebellum
9%
Diethylstilbestrol
6%
Evoked Potential
8%
Guillain-Barre Syndrome
8%
Immunotherapy
8%
Intravenous Immunoglobulin
8%
Lymphocyte Subpopulation
8%
Magnetic Resonance Imaging
24%
Magnetic Resonance Imaging
12%
Methylprednisolone
5%
Multiple Sclerosis
81%
Neopterin
8%
Nervous System Disorder
16%
Pelvis
8%
Placebo
8%
Progesterone
8%
Sex Hormone
8%
Soluble Interleukin 2 Receptor
9%
Stereotypic Movement Disorder
8%
T Cell
22%
Immunology and Microbiology
B Cell
5%
CD3 Antigen
5%
CD4
5%
Immunity
8%
Intravenous Immunoglobulin
8%
Lifespan
8%
Low Drug Dose
18%
Lymphocyte Subpopulation
8%
Lymphocytopenia
5%
Magnetic Resonance Imaging
8%
Measles
10%
Methylprednisolone
5%
Multiple Sclerosis
75%
Natural Killer Cell
6%
Prednisone
10%
Pregnancy
8%
Rib
8%
T Cell
16%
T Cell Activation
8%
